Inflammation and Coronary Artery Disease with Dr Paul Ridker

04/09/23 • 40 min

We would love to hear your thoughts on the episodes!

Dr Paul Ridker discusses his paper on residual inflammatory risk that was recently published in the Lancet with Dr. Thomas Nero. He discusses the pathology of inflammation as part of atherosclerosis, utilization of hs-CRP in clinical trials and in daily practice as well as current therapeutic options and ongoing investigations.

We would love to hear your thoughts on the episodes!

Previous Episode

Pragmatic Clinical Trials and EVOLVE-MI with Dr Christopher Cannon

We would love to hear your thoughts on the episodes!

Dr Christopher Cannon discusses the potential of Pragmatic Clinical Trials in our research armamentarium with Dr. Thomas Nero. They review the EVOLVE-MI trial for Early use of Evolocumab after Myocardial Infarction in detail and highlight the potential for future research.

Next Episode

$undefined - Lipids, Lipid Sub-fractionations and Inflammation, Putting It All Together with Dr Peter Toth$

Lipids, Lipid Sub-fractionations and Inflammation, Putting It All Together with Dr Peter Toth

We would love to hear your thoughts on the episodes!

Dr. Thomas Nero speaks with Dr. Peter Toth about the complex biology of lipids and atherosclerosis. In this episode Dr Toth dives into LDL goals, therapies for attenuating non-LDL risk, vascular biology and the where are research studies lead us in choosing therapies.